PharmStatus.com
Oncology Intelligence

PharmStatus
Competitive Intelligence


process The Pharmstatus team tracks clinical, financial, regulatory, and scholarly developments in drug development. Our team specializes in oncology pharmaceuticals, particularly targeted small molecule and biologics.
Let us help you to develop a tracking formula for your next marketing campaign.
Primary and secondary market research -- Industry landscape analysis -- Following and reporting industry trends -- Regulatory and clinical trial expertise.
New analyses available!
Therapeutics can evolve over a patient's treatment course to respond to the evolution of the patient's cancer.
What's hot and what's not in targeted oncology in 2015.
Innate immunity and targeted pathway combinations -- which ones for which patients?
Scalefree networks of metabolitic pathways -- scalefree networks of therapeutic targets.
Biosimilars, generics, and the pipeline.




Grant Consultation
The PharmStatus team can provide you with assistance in preparing and submitting grant proposals. We provide high quality proposals with rapid turnaround to meet tight deadlines helping businesses and academics obtain funding.
The team's expertise includes: US government grant and contract proposals, foundation grant proposals, industry landscape analysis, and alternative funding pathways.



Contact
Dr. Forrest Blocker Forrest Blocker, Ph.D., Managing Director
Dr. Blocker is an academic, who researches drug discovery and structural biology. Her research is focused on understanding the mechanisms of disease and drug design using computational and systems biology. She frequently consults and collaborates with scientists and biotechnology companies about drug discovery. Let's chat about your competitive intelligence and oncology education needs and questions.
 575-779-3686Skype: forrest.blocker      Email Me